Raggruppamento Terziario: Malattie Neuromuscolari

Filtra

Data

Body mass index in type 2 spinal muscular atrophy: a longitudinal study

Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy

Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes

Technology outcome measures in neuromuscular disorders: A systematic review

Hepatobiliary disease in XLMTM: a common comorbidity with potential impact on treatment strategies

Point-of-care lung and diaphragm ultrasound in a patient with spinal muscular atrophy with respiratory distress type 1

Psychosocial impact of sport activity in neuromuscular disorders.

Intrathecal administration of nusinersen in adult and adolescent patients with spinal muscular atrophy and scoliosis: Transforaminal versus conventional approach

Performance of Upper Limb module for Duchenne muscular dystrophy

Development of an academic disease registry for spinal muscular atrophy

Torna in alto